Kazakhstan Secures Supplies of Russian Coronavirus Vaccine Candidate


According to the information received, this information about the vaccine has been given by the local administration of Chengdu city. The clinical trials began at Pune's Bharti Vidyapeeth's Medical College and Hospital where two male volunteers were administered the vaccine.

He said the NHC had approved high-level production at a facility run by the China National Biotec Group (CNBG), the biological product arm of the government-owned pharmaceuticals company Sinopharm.

According to Golikova, clinical trials of another Russian coronavirus vaccine, which is being developed by the State Research Center of Virology and Biotechnology Vektor, are expected to be completed in late September. The adenovirus vector-based vaccine, developed by Moscow's Gamaleya Scientific Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund, was registered on August 11.

It is pertinent to note that Russian Federation claims to have developed the first COVID-19 vaccine Sputnik V, a human adenoviral vector vaccine that fights against the deadly coronavirus disease. "They (Russian government officials) have shared some information and data on Sputnik V, while more data related to the safety and efficacy of the vaccine is awaited", the source said.

"It is especially exciting that the clinical trial will test giving the vaccine through people's skin using a device without any needles as together with stable DNA vaccine technology this could be a major breakthrough in being able to give a future vaccine to huge numbers of people across the world". If Russia wishes to overcome this widespread scepticism it must conduct more extensive trials on the vaccine and offer greater transparency to the global community.

Singer Justin Townes Earle dies at 38
Singer-songwriter Allison Moorer, who has a son with ex-husband Steve Earle , wrote simply: "Rest, sweetheart". Earle grew up in his mother's home, largely estranged from his father for the first decade of his life.

"We've drawn up a series of plan packages, including medical consent forms, side-effects monitoring plans, rescuing plans, compensation plans, to make sure that the emergency use is well regulated and monitored", Zheng Zhongwei, head of China's coronavirus vaccine development task force, told state-run CCTV on Saturday.

The Oxford vaccine showed early promise in the first human trial when it produced an immune response, underlining its position as one of the leading candidates in the race to help vaccinate humans against the deadly novel coronavirus. The need for a vaccine is rising with the number of global coronavirus deaths surpassing 800,000.

Sinofarm, another pharma company in China, recently announced that by the end of this year, it could make a corona vaccine.

Moderna is now reporting interim data from the Phase 1 study, which includes new analysis from 20 additional people and details on how the vaccine performs in older people.